טוען...
Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI
In vivo gene therapy with adeno-associated viral (AAV) vectors is safe and effective in humans. We recently demonstrated that AAV8-mediated liver gene transfer is effective in animal models of mucopolysaccharidosis type VI (MPS VI), a rare lysosomal storage disease that is caused by arylsulfatase B ...
שמור ב:
הוצא לאור ב: | Mol Ther Methods Clin Dev |
---|---|
Main Authors: | , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
American Society of Gene & Cell Therapy
2017
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5552066/ https://ncbi.nlm.nih.gov/pubmed/28932756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2017.07.004 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|